"The study found that annual screening of all patients for STDR [sight-threatening diabetic retinopathy] was not cost-effective. Screening this entire cohort every 3 years was most likely to be cost-effective."
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
PH Scanlon, SJ Aldington, J Leal , R Luengo-Fernandez, J Oke , S Sivaprasad , et al.
Health Technology Assessment 2015;19(74)
Read more here.
No comments:
Post a Comment